Author: Kathleen Sharp
Edition: Reprint
Binding: Paperback
ISBN: 0452298504
Edition: Reprint
Binding: Paperback
ISBN: 0452298504
Blood Medicine: Blowing the Whistle on One of the Deadliest Prescription Drugs Ever
"Blood Feud rivals A Civil Action for best non-fiction book of the past twenty years. - John Lescroart, New York Times bestselling author of Damage
Procrit seemed like a biotech miracle, promising a golden age in medical care. Developed in the 1980s by Amgen and licensed to the pharmaceutical giant, Johnson & Johnson, the drug (AKA Epogen and Aranesp) soon generated billions in annual revenue-and still does.A In 2012, world famous cyclist, Olympian, and Tour de France champion Lance Armstrong was banned from professional cycling on doping charges for using EPO (the blanket name for the drugs Procrit and Epogen), resulting in a global controversy about abuse, big pharmaceutical compani Categories: Medicine - Pharmacology * General. Contributors: Kathleen Sharp - Author. Format: Paperback Read medical textbooks online like Blood Medicine here
Blood Medicine: Blowing the Whistle on One of the Deadliest Prescription Drugs Ever
Categories: Medicine - Pharmacology * General. Contributors: Kathleen Sharp - Author. Format: Paperback
Categories: Medicine - Pharmacology * General. Contributors: Kathleen Sharp - Author. Format: Paperback
Seller's Item Description: Title: Blood Medicine: Blowing the Whistle on One of the Deadliest Prescription Drugs Ever Author: Sharp, Kathleen ISBN: 9780452298507 Format: Paperback Condition: Brand New Publisher: Plume Comments: Visit Bargain Book Stores for more great deals! 100% Customer Satisfaction Guaranteed: We work hard to ensure 100% customer satisfaction. If you're having a problem with your order, we want to know about it and fix it to your satisfaction. Please allow us to resolve your
Blood Medicine : Paperback : Penguin Putnam Inc : 9780452298507 : 0452298504 : 28 Aug 2012 : ""Blood Feud" rivals "A Civil Action" for best non-fiction book of the past twenty years." -- John Lescroart, "New York Times" bestselling author of "Damage" Procrit seemed like a biotech miracle, promising a golden age in medical care. Developed in the 1980s by Amgen and licensed to the pharmaceutical giant, Johnson & Johnson, the drug (AKA Epogen and Aranesp) soon generated billions in annual revenue--and still does. In 2012, world famous cyclist, Olympian, and Tour de France champion Lance...
Blood Medicine Online
- John Lescroart, New York Times bestselling author of Damage
Procrit seemed like a biotech miracle, promising a golden age in medical care
A In 2012, world famous cyclist, Olympian, and Tour de France champion Lance Armstrong was banned from professional cycling on doping charges for using EPO (the blanket name for the drugs Procrit and Epogen), resulting in a global controversy about abuse, big pharmaceutical compani